Breast Cancer Patients' Views on the Use of Genomic Testing to Guide Decisions about Their Postoperative Chemotherapy

Publisher： Karger

E-ISSN： 1662-8063|16|3|110-117

ISSN： 1662-4246

Source： Public Health Genomics, Vol.16, Iss.3, 2013-04, pp. : 110-117

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Who Gets Genomic Testing for Breast Cancer Recurrence Risk?

By  

Public Health Genomics, Vol. 16, Iss. 5, 2013-07 ,pp. : 215-222

Karger

Access to resources Recommend Favorite

Testing for Hereditary Risk of Breast and Ovarian Cancer

By  

Public Health Genomics, Vol. 3, Iss. 4, 2001-05 ,pp. : 193-197

Karger

Access to resources Recommend Favorite

Factors Associated with the Use of Gene Expression Profiles in Estrogen Receptor-Positive Early-Stage Breast Cancer Patients: A Nationwide Study

By  

Public Health Genomics, Vol. 19, Iss. 5, 2016-08 ,pp. : 276-281

Karger

Access to resources Recommend Favorite

Attitudes of university students in Hong Kong about the use of genomic science and technology

By Hui Edwin   Chow Kathy   Leung Danny   Chan Hori   Wu Dorian  

New Genetics & Society, Vol. 31, Iss. 4, 2012-12 ,pp. : 323-341

Routledge Ltd

Access to resources Recommend Favorite

HER2 Evaluation and Its Impact on Breast Cancer Treatment Decisions

By  

Public Health Genomics, Vol. 15, Iss. 1, 2011-05 ,pp. : 1-10

Karger

Access to resources Recommend Favorite